Chemotaxis induced by SSc-IgG was significantly reduced by the AT1R antagonist valsartan and the ETAR antagonist sitaxsentan, but not the chemotaxis induced by HD-IgG. This evidence concerns the gene EDNRA and systemic sclerosis.